Ivermectin was first developed as a veterinary drug in the 1970s as an anti-parasitic, however, since 1988 it has been prescribed for humans as well. It was subsequently added to the World Health Organization’s list of essential medications. In 2015 the inventors were awarded the Nobel Prize in Medicine for their discovery/invention.
Since the emergence of COVID, 81 controlled studies and 33 random controlled trials conducted by 782 scientists with 128,840 patients in 27 countries were conducted to see if ivermectin is efficacious as a prophylactic and early treatment for COVID-19. These studies’ conclusions reveal dramatic positive outcomes for the use of ivermectin. When used prophylactically it was 83% effective; as an early treatment it was 63% effective; and when used as a later stage treatment it was 42% effective.
A report, published in The American Journal of Therapeutics, examined 18 randomized controlled studies on the use of ivermectin to control COVID. It concluded that the use of ivermectin “significantly reduced risks of contracting COVID-19” and “found large, statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance.” 
While many studies suggested that ivermectin was indeed a safe, cheap, and effective treatment for COVID, many public health policymakers refused to permit its use to treat and prevent COVID. The FDA in its statement said, the “FDA has not approved ivermectin for use in treating or preventing COVID-19” later explaining that “[t]he FDA has not reviewed data to support the use of ivermectin in COVID-19 patients to treat or to prevent COVID-19.”
Advocating for the use of ivermectin is Dr. Pierre Kory, a founder of the Front Line COVID-19 Critical Care Alliance (FLCCC). Kory, along with the other professionals at the FLCCC developed the specific protocol to prevent and treat COVID using ivermectin. While the treatment was shunned by the medical establishment and social media companies banned promoting and debating the treatment, physicians, like Kory, persisted in advocating for its use.
In December 2020 Dr. Kory and others gave an impassioned plea, backed by scientific research, at a committee hearing in the U.S. Senate stating that ivermectin “basically obliterates transmission of this virus” with “miraculous effectiveness”. The doctor continued, saying that the “scientific recommendation [is] based on mountains of data that have emerged in the last three months”.
The U.S military, based on leaked documents, also acknowledged that ivermectin “works throughout all phases” of COVID-19. 
Many hospitalized patients were refused ivermectin and had to get a court order to force the hospital to permit them to use this life-saving medication. 
Use across the world:
Ivermectin has been used in many countries but has been approved in just a few including South Africa, Slovakia, Belize, and Bolivia.
Peru used ivermectin across 24 states and saw that “excess deaths at +30 days [after the day of peak deaths] dropped by a population-weighted mean of 74%.” 
Uttar Pradesh in India implemented widespread use of ivermectin to prevent infection, and as an early treatment. The state’s Health Department credited its use with reducing infections and deaths despite the state being one of the most densely populated areas in India.
The Brazilian city of Itajai hosted a wide-scale program using ivermectin as a prophylactic, the study concluded that it reduced COVID infections by 45% over a seven-month period.
The Ivermectin Story:
The Case for Ivermectin: https://rumble.com/vdw19d-the-case-for-ivermectin.html
For more information visit:
The above information is not medical advice and should not be taken as such; for medical advice speak with your healthcare practitioner.
 https://translate.google.com/translate?sl=auto&tl=en&u=https://bratislava.zoznam.sk/kauza-ivermectin-zistovali-sme-kde-sa-da-zohnat-a-kedy-bude-k-dispozicii-v-nasich-lekarnach/ https://trialsitenews.com/slovakia-becomes-the-first-eu-nation-to-formally-approve-ivermectin-for-both-prophylaxis-and-treatment-for-covid-19-patients/
Email questions or comments to [email protected]